Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine neuroprotection in brain tumor surgery
PACTR202008567047887Phase 3Recruiting
- Sponsor
- Mona Raafat Elghamry
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexmedetomidine in brain cancer (2 arms), sponsored by Mona Raafat Elghamry. Primary endpoint: cerebral oxygen extraction ratio. Started Aug 2020; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
brain cancer
Beyond the preview
Go deeper on PACTR202008567047887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202008567047887.